Food and Drug Administration (FDA) — 2020 Investments
3 investments dated 2020 · listed companies and verified rows first · show all
Functional Fluidicsfunctionalfluidics.comin𝕏Sep 2020 · $168.1K
Functional Fluidics develops diagnostic tools to objectively monitor red blood cell health in patients with Sickle Cell Disease.
BiotechHealthtechMedical DevicesDetroit, US
John Cunningham(Chief Operating Officer)Patrick Hines(CEO & Founder)
NANOHMICS INCnanohmics.comSep 2020 · $1.2M
Nanohmics develops a chip-scale snapshot hyperspectral image sensor that integrates into standard COTS imaging systems with minimal size, weight, and power impact.
Deep TechHardwareSemiconductors
RPRD Diagnostics, LLCrprdx.comSep 2020 · $168.1K
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.